Tightening Regulations And Raising Standards In UK Marketing Communications: The New ABPI Code Of Practice 2008 Explained
KeywordPharma Expert Reviews are FREELY available to download and pass on thanks to support from relevant sponsors. Our brand new title, just published today, Tightening Regulations and Raising Standards in UK Marketing Communications: the new ABPI Code of Practice (2008) explained, has been sponsored by Wolters Kluwer and is described below.
U.S. EPA Licenses Simulations Plus' ADMET Predictor trade; Software
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, announced that it has received a purchase order from the U.S. Environmental Protection Agency for its ADMET Predictor™ software.
Incentives To Develop Medicines For Neglected Diseases Highlighted At 2008 BIO International Convention
The Biotechnology Industry Organization (BIO) announced the release of a paper outlining incentives to encourage innovation for neglected diseases. The paper, written by BIO's health economist Ted Buckley, PhD, is being released during the 2008 BIO International Convention, taking place June 17-20, 2008 at the San Diego Convention Center in San Diego, Calif.
CCA Responds To Government And Industry Price Deal
The CCA has issued its initial response to today's announcement that a significant deal has been reached by the Government and the pharmaceutical industry on parts of the new Pharmaceutical Price Regulation Scheme. Rob Darracott, CCA CEO comments: "How these price changes play through the supply chain is the issue of fundamental importance for our members.
Biologics Sales Increased 12.5 In 2007 To 75B, Nearly Double 6.4 Increase Of Traditional Pharmaceuticals
Worldwide sales of biologic medications increased by 12.5% in 2007 to $75 billion, nearly double the 6.4% increase in sales of traditional pharmaceuticals, according to a recent report by IMS Health, the Newark Star-Ledger reports. However, the increase was not as high as 2006, when sales increased by 18.
BIO And ABLE-India Announce First Biotechnology Partnering Event In India
The Biotechnology Industry Organization (BIO) and the Association of Biotechnology Led Enterprises (ABLE), a national forum that represents the Indian biotechnology sector, today announced a two-day annual biotechnology partnering meeting to be held in Hyderabad, India.
GE Animal Technologies Promise To Enhance Human Health
Genetically engineered (GE) animals provide innovative technologies that are transforming public health through biomedical, food and environmental applications, according to a scientific report released at the BIO 2008 International Convention .
Euro Nippon Kayaku GmbH Withdraws Its Marketing Authorisation Application For Spanidin gusperimus , Europe
The European Medicines Agency (EMEA) has been formally notified by Euro Nippon Kayaku GmbH of its decision to withdraw its application for a centralised marketing authorisation application for the medicine Spanidin (gusperimus) 50 mg/ml powder for solution for injection.
HealthLinx And InSymbiosis To Co-Develop Therapeutic For Lung Disease
HealthLinx Limited (ASX:HTX) and Canadian-based InSymbiosis Discovery Inc (InSymbiosis) have signed a Letter of Intent to co-develop HTX's peptide therapeutic CR014 and related compounds for applications in Acute Respiratory Distress Syndrome (ARDS) and Acute Lung Injury.
Drugs With Fewer Side Effects
A Duke University chemist has apparently solved a long-standing frustration in creating certain synthetic molecules that make up drugs, which could lead to better drugs with fewer side effects.Like human hands, many molecules that make up drugs come in two shapes, right and left.